Insider · CIK 0001520392
Michael Greiner
Files at AVNS (AVANOS MEDICAL, INC.). First filing Mar 15, 2024, latest Mar 15, 2024.
In brief
Michael Greiner files SEC Form 4 as CEO and CFO at AVNS (AVANOS MEDICAL, INC.). Since Mar 15, 2024, Michael Greiner has reported 0 open-market buys worth $0 and 1 open-market sell worth $153k, the latest filed on Mar 15, 2024.
A track record needs three past buys with six months of prices behind them; Michael Greiner has 0, so none is measured yet.
The newest scored trade: sold $153k of AVNS on Mar 14, 2024, filed Mar 15, 2024, scored 33 (weak).
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 14, 2024 | AVNS AVANOS MEDICAL, INC. | 8,000 0.02% of outstanding | $153k | Mar 14, 2024 | none |
Transactions
Every row this insider has filed, 23 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 13, 2025 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -19,771 | $12.43 | $246k | 204,493 | May 14, 2025 |
| May 13, 2025 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -4,474 | $12.43 | $56k | 200,019 | May 14, 2025 |
| Mar 7, 2025 | AVNS AVANOS MEDICAL, INC. | AGrant or award Common Stock | +34,316 | $0.00 | $0 | 224,264 | Mar 11, 2025 |
| Mar 7, 2025 | AVNS AVANOS MEDICAL, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +73,633 | $0.00 | $0 | 73,633 | Mar 11, 2025 |
| Mar 6, 2025 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -5,112 | $15.30 | $78k | 198,433 | Mar 10, 2025 |
| Mar 6, 2025 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -8,485 | $15.30 | $130k | 189,948 | Mar 10, 2025 |
| Mar 4, 2025 | AVNS AVANOS MEDICAL, INC. | MOption exercise Common Stock | +12,149 | $0.00 | $0 | 214,235 | Mar 6, 2025 |
| Mar 4, 2025 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -6,048 | $15.13 | $92k | 208,187 | Mar 6, 2025 |
| Mar 4, 2025 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -4,642 | $15.13 | $70k | 203,545 | Mar 6, 2025 |
| Dec 3, 2024 | AVNS AVANOS MEDICAL, INC. | AGrant or award Common Stock | +10,000 | $0.00 | $0 | 200,898 | Dec 5, 2024 |
| Oct 29, 2024 | AVNS AVANOS MEDICAL, INC. | AGrant or award Common Stock | +44,189 | $0.00 | $0 | 190,898 | Oct 31, 2024 |
| Mar 18, 2024 | AVNS AVANOS MEDICAL, INC. | MOption exercise Common Stock | +4,219 | $0.00 | $0 | 155,714 | Mar 19, 2024 |
| Mar 18, 2024 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -1,892 | $19.09 | $36k | 153,822 | Mar 19, 2024 |
| Mar 18, 2024 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -7,113 | $19.09 | $136k | 146,709 | Mar 19, 2024 |
| Mar 14, 2024 | AVNS AVANOS MEDICAL, INC. | SOpen-market sale Common Stock | -3,800 | $19.11 | $73k | 155,695 | Mar 15, 2024 |
| Mar 14, 2024 | AVNS AVANOS MEDICAL, INC. | SOpen-market sale Common Stock | -714 | $19.12 | $14k | 154,981 | Mar 15, 2024 |
| Mar 14, 2024 | AVNS AVANOS MEDICAL, INC. | SOpen-market sale Common Stock | -2,231 | $19.13 | $43k | 152,750 | Mar 15, 2024 |
| Mar 14, 2024 | AVNS AVANOS MEDICAL, INC. | SOpen-market sale Common Stock | -337 | $19.14 | $6,450 | 152,413 | Mar 15, 2024 |
| Mar 14, 2024 | AVNS AVANOS MEDICAL, INC. | SOpen-market sale Common Stock | -808 | $19.15 | $15k | 151,605 | Mar 15, 2024 |
| Mar 14, 2024 | AVNS AVANOS MEDICAL, INC. | SOpen-market sale Common Stock | -110 | $19.16 | $2,108 | 151,495 | Mar 15, 2024 |
| Mar 6, 2024 | AVNS AVANOS MEDICAL, INC. | AGrant or award Common Stock | +57,471 | $19.14 | $1.1M | 164,613 | Mar 7, 2024 |
| Mar 6, 2024 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -5,118 | $19.00 | $97k | 159,495 | Mar 7, 2024 |
| Mar 5, 2024 | AVNS AVANOS MEDICAL, INC. | FTax withholding Common Stock | -4,991 | $18.76 | $94k | 106,312 | Mar 6, 2024 |
Questions about Michael Greiner
Answered from the filings on this page, as of the latest one.
Is Michael Greiner buying or selling?
Not in the last 12 months. Michael Greiner's latest open-market trade on SEC Form 4 was sold $153k of AVNS on Mar 14, 2024.
How did Michael Greiner's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Michael Greiner has 0.
Where does Michael Greiner file Form 4?
Michael Greiner has filed Form 4 at AVNS (AVANOS MEDICAL, INC.) as SVP - Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.